Saving Limbs. Saving Lives.

Protecting patients from serious, life-altering complications stemming from plaque and thrombus induced micro-circulatory injury & contrast-induced renal injury during Peripheral Artery Disease interventions.

How Protexa is different

Challenging the Status Quo

PAD interventions liberate micro & macro-emboli. For too long this has been deemed "the cost of doing business" when treating this patient population.

>800K US Cases/Yr

Peripheral Arterial Disease (PAD) is on the rise. The increasing severity of the disease has increased the complexity of interventions.

Occurence

Micro-circulatory injury resulting from downstream migration of thrombus & plaque post-intervention. All interventions liberate debris.

Difficult to Detect

Purpose Built Solution

The Protexus Catheter

Protexa is primed to transform the standard of care in PAD treatment through its innovation in the Protexus catheter.

The Protexus - Numerous clinical advantages

Simplifying Procedures

One Device, a multitude of benefits. Only platform in PAD to capture micro & macro debris. Protect from micro and macro-circulatory injury. Reduce contrast exposure. Enabling active aspiration thrombectomy. Support for lesion crossing while eliminating the need for utilization of a guide/support catheter. Streamline procedural workflow.

Team

Pioneering Novel Advancements

Protexa Endovascular is devoted to improving life for patients suffering from vascular disease.

  • Designed by Clinicians for Clinicians

  • Decades of Expertise in PAD with Diverse Team of KOL's Serving on Medical Advisory Board

  • Founding Executive Team has Deep Expertise Designing, Developing & Commercializing Meaningful Medical Device Innovations

  • Ryan Balko, CEO & Co-Founder

  • Dr. Richard Fulton, CTO & Co-Founder

  • Dr. Peter Schneider, CMO & Co-Founder

  • Dr. John Rundback, Board Member & Co-Founder

  • Christopher Owens, Board Member

  • Bruce Shook, Board Member

  • Dr. Miguel Montero-Baker, Medical Advisory Board

  • Dr. Jay Mathews, Medical Advisory Board

  • Dr. Joseph Steele, Medical Advisory Board

  • Dr. Patrick Geraghty, Medical Advisory Board

Contact Us

Protexa Endovascular

Interested in learning more?

© Untitled. All rights reserved. Protexa and Protexus are trademarks of Protexa Endovascular, Inc.

Thank you!